论文部分内容阅读
目的:对采用介入化疗栓塞与放疗联合的方法治疗中晚期肝癌的临床效果进行比较分析。方法:抽取96例在我院临床就诊的患者,将他们随机分为单纯介入和联合介入两组,平均每组48例。单纯介入组患者采用放疗的方法进行治疗;联合介入组患者采用介入化疗栓塞与放疗联合的方法进行治疗。对两组患者的临床治疗效果、并发症和不良反应情况进行比较分析。结果:联合介入组患者的中位生存时间明显长于单纯介入组患者,有显著的统计学差异(P<0.05);该组患者治疗后半年和一年内的生存率明显高于单纯介入组,有显著的统计学差异(P<0.05);两组患者在治疗的过程中均出现了骨髓抑制等不良反应和并发症现象,但人数基本相同,没有显著的统计学差异(P>0.05)。结论采用介入化疗栓塞与放疗联合的方法进行中晚期肝癌治疗的临床效果十分明显,可以使患者中位存活时间显著提高,使该病患者在半年和一年内的存活率显著提高,可以作为今后临床对该类患者进行治疗的首选方法。
Objective: To compare the clinical effects of interventional chemotherapy with embolization and radiotherapy in the treatment of advanced liver cancer. Methods: Ninety-six patients in our hospital were enrolled in the study. They were randomly divided into two groups: simple intervention and combined intervention, with an average of 48 in each group. Patients in the interventional group were treated with radiotherapy alone. Patients in the combined intervention group were treated with interventional chemoembolization combined with radiotherapy. The two groups of patients with clinical effects, complications and adverse reactions were compared. Results: The median survival time in the intervention group was significantly longer than that in the intervention group (P <0.05). The survival rates in the six months and one year after treatment in the two groups were significantly higher than those in the simple intervention group (P <0.05). Both groups experienced adverse reactions such as myelosuppression and complications during the treatment, but the numbers were basically the same with no significant difference (P> 0.05). Conclusions Interventional chemotherapy and embolization combined with radiotherapy in the treatment of advanced hepatocellular carcinoma has obvious clinical effect, which can significantly improve the median survival time of patients, so that the patients in six months and one year survival rate significantly increased, and can be used as future clinical The preferred method of treatment for such patients.